Multiple Sclerosis

A Patient Journey Solution (Part 3): Digitally Enabled V1C
A solution to convoluted autoimmune patient journeys?

Digitally enabled, virtual first care (V1C) offers a potential solution to convoluted autoimmune patient journeys. V1C especially offers significant advantages for autoimmune and inflammatory disease (AIID) patients in accessing specialized care. Virtual specialist practices get patients to a rheumatologist or gastroenterologist much faster (days rather than months) and with less

Read More »

Specialty Pharmaceuticals: The Highest Autoimmune Cost

Invisible Epidemic of Autoimmune Disease As we continue to illuminate the hidden costs of the long-ignored epidemic of autoimmune disease (AIID), we must shine a light on the highest autoimmune cost: Specialty pharmaceuticals. Current data largely underestimate total AIID costs, and accurate numbers are few and far between. Through our

Read More »

The Total Cost Burden of the Autoimmune Epidemic

The Problem: We Don’t Really Know! The problem with estimating the total cost burden of the autoimmune disease (AIID) epidemic is that we really don’t know! A May 2022 NIH report validates our long-held belief that missing and inconsistent data for autoimmune diseases (AIIDs) are at the root of the

Read More »

Spotlight on Multiple Sclerosis

“The first neurologist I went to see about my MS brushed off my questions and concerns about medications and made me feel helpless, as if no matter what lifestyle changes I made, MS would cripple me…” – anonymous patient participant in our “Autoimmunity Voices” survey Patient stories such as this

Read More »

Vegetables: A Diet Must-Have!

Vegetables have always been the vanguard to healthy eating. Seemingly since the dawn of time, parents have struggled to ensure their resistant children get enough greens. At least, until the point when they realize that eating these bland, sometimes bitter, leaves are actually a worthy sacrifice in the name of

Read More »

Autoimmunity Voices

About Us: Although digital health commands $4B in funding, autoimmune diseases have remained wallflowers at the party. So, how do we make this lonely world of autoimmune disease not so lonely? Currently, there is a huge unmet need in autoimmune disease. These not-obvious – under the surface – invisible –

Read More »

AARDA: An Idea Ahead of Its Time

An Overlooked Disease Autoimmune disease (AD) is a drastically underappreciated problem. There are 80-100 ADs, and researchers suspect that 40 additional diseases have an autoimmune element. AARDA estimates that 50 million Americans suffer from autoimmune disease, but there appears to be an increasing incidence in young adults. AD is responsible

Read More »